Clinical Trial Update: Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors [Phase 1]

View source ↗

Summary

Phase I study of SYS6043 in patients with advanced or metastatic solid tumors is currently recruiting, including prostate cancer, small cell lung cancer, ovaria…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Ovarian Cancer
• Prostate Cancer
• Small Cell Lung Cancer

Drugs mentioned

• SYS6043

Snippet

Sponsor: Conjupro Biotherapeutics, Inc. | Conditions: Cancer, Solid Tumor Cancer | Phase 1 | Status: RECRUITING